VEGFA and neoplasm: Bevacizumab prevents the interaction of VEGF-A with VEGFR by binding to VEGF-A, inhibiting the activation of VEGF signaling pathway, thereby preventing the formation of new blood vessels (15).Bevacizumab inhibits the growth of human tumor cell lines because of this mechanism.